share_log

Navidea Biopharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Witter Malcolm G

SEC ·  Dec 1, 2022 08:27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more